Enpresse
NDC Package 21695-855-01
Package Information
Enpresse is this combination hormone medication is used to prevent pregnancy. Marketed by Rebel Distributors Corp, this product is identified by NDC 21695-855 and is authorized under FDA application ANDA075809.
Identification & Billing
- RxCUI: 310230 - ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet
- RxCUI: 348804 - ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet
- RxCUI: 348804 - ethinyl estradiol 30 MCG / levonorgestrel 125 MCG Oral Tablet
- RxCUI: 348805 - ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet
- RxCUI: 348805 - ethinyl estradiol 40 MCG / levonorgestrel 75 MCG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 21695 - Rebel Distributors Corp
- 21695-855 - Enpresse
- 21695-855-01 - 6 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
- 21695-855 - Enpresse
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 21695-855-01 identifies a specific commercial package of 6 pouch in 1 carton / 1 blister pack in 1 pouch / 1 kit in 1 blister pack of Enpresse, labeled by Rebel Distributors Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 6 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on December 20, 2010. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: a progestin and an estrogen. It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. If a fertilized egg does not attach to the uterus, it passes out of the body. Besides preventing pregnancy, birth control pills may make your periods more regular, decrease blood loss and painful periods, decrease your risk of ovarian cysts, and also treat acne. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).
How is this Rebel Distributors Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695085501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.